Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic sphenopalatine ganglion block with Botox in intractable cluster headache
2012-000248-91Phase 2Completed
- Sponsor
- Department of Neuromedicine and Movement Science, NTNU
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in Cluster Headache (CH), sponsored by Department of Neuromedicine and Movement Science, NTNU. Primary endpoint: Safety aspects. Started May 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2012-000248-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000248-91.